萊
LXRX
萊斯康製藥
2.180
-0.030-1.36%After Hours: 2.162 -0.018 -0.84%19:41 05/29 EDT
OPEN/PREV CLOSE2.090/2.070
TODAY RANGE1.940-2.090
VOL1.77M
MARKET CAP863.96M
52 WEEK RANGE0.6150-2.530
AVG VOL (3M)2.63M
% TURNOVER0.40%
TURNOVER--
P/E (TTM)-27.2028
% RANGE7.25%
EPS(TTM)-0.0715
P/E(FORWARD)-12.5484
P/B4.063
BVPS0.4787
DIVIDEND--
P/S14.20
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP855.50M
SHARES OUTSTANDING444.20M
NEXT EARNINGS08/04-08/10
FREE FLOAT439.84M
LOT SIZE1
EX-DATE05/21/2015
News
Press Releases
Financial Reports
Profile
Seeking Alpha·5d ago
SA analyst upgrades/downgrades: SMCI, AMZN, SFM, LXRX
Seeking Alpha·6d ago
Lexicon Pharmaceuticals: Uncertainty Clouds The Bull Case (Rating Downgrade)
Benzinga·05/11 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
Dow Jones·05/11 15:19
Lexicon Pharma Is Maintained at Buy by Citigroup
Dow Jones·05/11 15:19
Lexicon Pharma Price Target Raised to $3.10/Share From $2.30 by Citigroup
Benzinga·05/11 15:10
Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.1
TipRanks·05/11 11:01
Lexicon price target raised to $3.10 from $2.30 at Citi
TipRanks·05/07 19:12
Lexicon reports Q1 EPS 0c, consensus (4c)
Reuters·05/07 11:41
Lexicon Pharmaceuticals Q1 net loss narrows
Seeking Alpha·05/07 11:41
Lexicon Pharmaceuticals reports Q1 results
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.